Camcon Medical

What Camcon Medical does

Camcon Medical Ltd is a Cambridge, UK-based private medical device company that applies its patented Binary Actuation Technology (BAT) to precision oxygen and nitric oxide delivery in healthcare. BAT is a proprietary valve mechanism that opens and closes in 6 milliseconds, using internal kinetic-energy recycling and a permanent-magnet fail-safe locking system to provide rapid, low-energy, two-state flow control of gases without continuous power to maintain position. The company's product portfolio centers on two registered-trademark devices: IMOD® (Intelligent Medical Oxygen Delivery), a responsive oxygen therapy system that delivers oxygen only during inhalation via nasal cannula or face mask, reducing oxygen consumption by up to 66% versus continuous supply; and BiMOD® (Binary Intelligent Medical Oxygen Delivery), a next-generation device employing two BAT valves to deliver precision doses of oxygen and nitric oxide timed to the beginning of each breath for patients with respiratory failure. The company targets NHS hospitals, critical care units, and home-care respiratory patients (COPD, COVID-19 pneumonia, obstructive sleep apnoea), and is pursuing clinical trials with Royal Papworth Hospital and prior validation by Cambridge University Hospitals NHS, plus a randomized controlled trial conducted with the University of Vienna in severely hypoxic COPD patients.

The business model is hardware sales of regulated medical devices, executed through a collaborative, enterprise-field-sales motion: direct engagement with NHS and UK healthcare institutions for clinical evaluation and adoption, alongside an explicit stated intent to partner with major healthcare players for international approvals, certification, marketing, and distribution. Pricing is not publicly disclosed and is negotiated via direct contact. Camcon Medical is part of the Camcon Federation of Companies founded by Daniel Chapchal and Wladyslaw Wygnanski (the BAT inventor) in 1999, with Lord David Young as Federation Chairman; the technology originated in 1998 and was previously applied in automotive and oil & gas industries before being adapted to healthcare. Revenue is not disclosed, no institutional funding rounds are recorded in the source data, and the company operates with 1–10 employees, indicating an early-clinical-stage commercial posture rather than scaled market presence.

Name

Camcon Medical

Legal name

Camcon Medical Ltd

Website

https://camcon-medical.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

Camcon Medical is a Cambridge, UK private medical device company that applies its patented Binary Actuation Technology to deliver precision oxygen and nitric oxide via IMOD® and BiMOD® devices, targeting NHS hospitals, critical care units, and home-care respiratory patients.

Ownership category

akta.pro rank

Product category

Respiratory Care Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD)

akta.pro secondary industry

Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)

Keywords

• Medical oxygen delivery
• Respiratory care devices
• Precision gas flow control
• Binary Actuation Technology
• Critical care ventilation

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of medical devices including IMOD and BiMOD oxygen delivery systems to healthcare providers, hospitals, and for home care use

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Camcon Medical develops and manufactures precision medical gas delivery devices based on its patented Binary Actuation Technology (BAT). Its flagship products are IMOD® (Intelligent Medical Oxygen Delivery) and BiMOD® (Binary Intelligent Medical Oxygen Delivery), which provide responsive, breath-synchronized delivery of oxygen and nitric oxide for hospitals, critical care units, and home respiratory care.

Product overview

Camcon Medical is a medical technology company that has developed a proprietary Binary Actuation Technology (BAT) platform at the core of its product portfolio. The BAT technology enables rapid, precise, and energy-efficient control of fluid and gas flow. The company offers two main medical device products: IMOD® (Intelligent Medical Oxygen Delivery) for responsive oxygen therapy that monitors and adjusts to individual patient breathing patterns, and BIMOD® (Binary Intelligent Medical Oxygen Delivery) for precision co-delivery of oxygen and nitric oxide. Both products leverage BAT's fast-acting valve technology to deliver medical gases only during inhalation, significantly reducing waste and improving patient outcomes.

Differentiator

Problem solved

Functional benefit

Brands

• IMOD®: Intelligent Medical Oxygen Delivery system - a responsive oxygen therapy device using Binary Actuation Technology to monitor and automatically adjust to a patient's oxygen requirements.
• BiMOD®

Products and services

• Binary Actuation Technology (BAT) Proprietary valve technology platform providing rapid (6-millisecond), precise, and low-energy flow control of liquids and gases via fail-safe, energy-recycling mechanisms. BAT is licensed/applied across Camcon subsidiaries including Camcon Medical for healthcare applications.
• IMOD® (Intelligent Medical Oxygen Delivery) Responsive oxygen therapy device using BAT that monitors and automatically adjusts to a patient's individual oxygen requirements. Delivers oxygen reactively through nasal cannula or face mask, activated only during inhalation, reducing oxygen consumption by up to 66% compared to continuous supply. Designed for NHS hospitals, critical care units, and home respiratory care patients.
• BiMOD® (Binary Intelligent Medical Oxygen Delivery) Next-generation precision oxygen delivery device using two BAT valves to simultaneously deliver precise doses of oxygen and nitric oxide at the beginning of each breath. Targets well-ventilated lung regions to optimize gas exchange in spontaneously breathing patients with respiratory failure (including COPD and COVID-19 pneumonia).

Quantifiable outcome

• Up to 66% oxygen savings compared to continuous supply
• +5 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered supporting, core and flagship.

• Audient HealthsupportingGTM or Marketing PartnerAudient Health is the administrator of the Camcon Medical website and handles media/journalist enquiries. They collect and store media enquiry information in accordance with their own privacy policy.
• Royal Papworth HospitalcoreStrategic or Co-development PartnerCamcon Medical is undertaking physiological studies and clinical trials with Royal Papworth Hospital to demonstrate superior efficacy of BiMOD over CPAP and HFNO in critical care patients with respiratory failure. This is a key partnership for medical device approval.
• University of ViennacoreStrategic or Co-development PartnerProfessor Tim Higenbottam conducted a 3-month randomised controlled trial in collaboration with University of Vienna studying severely hypoxic COPD patients, which demonstrated enhanced gas exchange, improved lung blood flow, and indication of increased exercise capacity.
• Cambridge University Hospitals NHScoreStrategic or Co-development PartnerIMOS Device Clinical Insight and Technical Validation Report was produced by Cambridge University Hospitals NHS in June 2014, validating the technology for clinical use.
• Camcon Federation of CompaniesflagshipOthersCamcon Federation of Companies is the parent organization founded by Daniel Chapchal and Wladyslaw Wygnanski. It includes multiple subsidiaries applying BAT technology across different industries including Camcon Medical for healthcare, Camcon Automotive, and Silverwell.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Philips Respironics: Dominant incumbent in respiratory care and oxygen therapy with broad hospital and home care portfolio. Directly competes with Camcon Medical's IMOD/BiMOD in oxygen delivery but serves many other device categories; represents the primary competitive threat with established reimbursement, clinical evidence, and global distribution.
• Drägerwerk:

Direct peers

• Fisher & Paykel Healthcare: Specialist in respiratory humidification, CPAP, and high-flow nasal oxygen (HFNO) systems. Competes head-to-head with BiMOD in critical care respiratory failure applications and is being directly compared to BiMOD in Royal Papworth clinical trials.
• ResMed: Global leader in sleep apnoea (CPAP) and connected oxygen therapy devices. Directly competes with Camcon's planned sleep apnoea application of BAT and shares the same NHS hospital and home-care customer base; Camcon's silent valve technology targets the same adherence gap ResMed's CPAP currently dominates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/camcon-medical-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Camcon Medical